Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...
Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...
NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...
Please provide your email address to receive an email when new articles are posted on . The Stentrode brain-computer interface offers a non-invasive, nonsurgical solution for paralysis. Additional ...
Blood vessel brain implant brings mind control to Apple's spatial computer Rather than cut a chunk of skull away to install a brain-computer interface like Neuralink, Synchron feeds electrodes up ...
These are exciting times at the intersection of artificial intelligence (AI) and neuroscience. The trend in brain-computer interfaces (BCIs) is toward flexible and less invasive devices that can ...
When a new technology shows promise, performance-wise and commercially, innovation does not stop. To the contrary, it gathers pace. New medical devices typically emerge from competing groups of ...
Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand operations and accelerate commercialization of its nonsurgical brain-computer interface (BCI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results